Tiburon, California, United States, February 2025 – Ledger Run, a leading provider of advanced technology software solutions for clinical trials, today announced that Gary Lubin, who founded the company and has served as CEO, will retire on March 1, 2025, and remain on the Board of Directors. The company has appointed John Chinnici, a seasoned executive with a proven track record of driving growth, as its new CEO.
During his tenure, Mr. Lubin grew Ledger Run into a leading technology company in the clinical trial operations market. Driven by Mr. Lubin’s vision and leadership, Ledger Run has developed into a market leader with an unwavering commitment to provide the best technology and services to support the development of new medical treatments. During his four decades in the industry, he founded, invested, and led many transformative efforts. His commitment to building a company where the culture reflects its purpose to serve customers and be a great place to work is upheld by its highly engaged staff located around the globe.
Ledger Run has a list of marquee customers, over a thousand studies active on its ClinRun™ platform, and supports more than twenty-thousand clinical sites in over forty countries. “It has been an honor to have founded and served as its CEO for all these years, and I am excited to have John take the reins,” said Gary Lubin. “With a strong team in place, a top technology platform that continues to get better, strong customer relationships, together with John’s experience in leading and growing business, I am very optimistic for Ledger Run’s next chapter.”
Mr. Chinnici brings more than 25 years of experience running and scaling software and services companies. Mr. Chinnici has spent most of his career serving the life sciences industry, first at Accenture and IBM and then as an early leader at Veeva Systems, driving much of its rapid growth. Most recently, Mr. Chinnici led the Insights division at Inovalon, a healthcare software and data company. “I am excited to build on the great legacy Gary has established, for the privilege to serve Ledger Run’s tremendous customer base, and the opportunity to work with the amazing Ledger Run team,” John remarked.
“On behalf of the Board, I want to express our deepest gratitude to Gary for his leadership, vision, and unwavering commitment to the Company. His dedication to fostering a collaborative, creative culture, and innovative application of technologies, has been instrumental in Ledger Run’s success,” said John Durrett, Partner at Blue Star Innovation Partners, Ledger Run Executive Sponsor and Board of Directors Member. “The Board is delighted to have John join Ledger Run as their next CEO. He is the ideal person to take over the leadership of the Company as we continue to grow and bring transformative technologies to the industry.”
About Ledger Run
Ledger Run is transforming clinical trial business operations through an innovative suite of trial management solutions. ClinRun™, Ledger Run’s next-generation software suite for budgeting, contracting, payments, and forecasting, automates manual tasks, reduces errors, and speeds cycle times while promoting engagement among sponsors, CROs, and investigator sites. ClinRun™ is simple to implement and can manage even the most complex studies.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
